Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
NCT03402386Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vadadustat in anemia, sponsored by Mitsubishi Tanabe Pharma. Started Jan 2018; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03402386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402386.